[TREATMENT OF EPILEPSY WITH 3-ETHOXYCARBO-5,5-DIPHENYLHYDANTOIN (P-6127), A NEW ANTICONVULSANT].
D000927:Anticonvulsants; D001259:Ataxia; D001774:Blood Chemical Analysis; D004358:Drug Therapy; D004569:Electroencephalography; D004827:Epilepsy; D004832:Epilepsy, Absence; D004830:Epilepsy, Tonic-Clonic; D006801:Humans; D006827:Hydantoins; D006965:Hyperplasia; D009207:Myoclonus; D009759:Nystagmus, Pathologic; D010672:Phenytoin; D012640:Seizures; D014116:Toxicology
D000927:Anticonvulsants; D006827:Hydantoins; D010672:Phenytoin; C098839:5-phenylhydantoin
ANTICONVULSANTS; ATAXIA; BLOOD CHEMICAL ANALYSIS; DRUG THERAPY; ELECTROENCEPHALOGRAPHY; EPILEPSY, GRAND MAL; EPILEPSY, PETIT MAL; HYDANTOINS; HYPERPLASIA; JACKSONIAN SEIZURE; MYOCLONUS; NYSTAGMUS; TOXICOLOGIC REPORT